283 related articles for article (PubMed ID: 26855092)
1. Successful Oocyte Cryopreservation in Reproductive-Aged Cancer Survivors.
Druckenmiller S; Goldman KN; Labella PA; Fino ME; Bazzocchi A; Noyes N
Obstet Gynecol; 2016 Mar; 127(3):474-480. PubMed ID: 26855092
[TBL] [Abstract][Full Text] [Related]
2. Planned oocyte cryopreservation-10-15-year follow-up: return rates and cycle outcomes.
Blakemore JK; Grifo JA; DeVore SM; Hodes-Wertz B; Berkeley AS
Fertil Steril; 2021 Jun; 115(6):1511-1520. PubMed ID: 33712289
[TBL] [Abstract][Full Text] [Related]
3. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.
Goldman RH; Racowsky C; Farland LV; Munné S; Ribustello L; Fox JH
Hum Reprod; 2017 Apr; 32(4):853-859. PubMed ID: 28166330
[TBL] [Abstract][Full Text] [Related]
4. Association of Fresh Embryo Transfers Compared With Cryopreserved-Thawed Embryo Transfers With Live Birth Rate Among Women Undergoing Assisted Reproduction Using Freshly Retrieved Donor Oocytes.
Insogna IG; Lanes A; Lee MS; Ginsburg ES; Fox JH
JAMA; 2021 Jan; 325(2):156-163. PubMed ID: 33433574
[TBL] [Abstract][Full Text] [Related]
5. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles.
Law YJ; Zhang N; Venetis CA; Chambers GM; Harris K
Hum Reprod; 2019 Sep; 34(9):1778-1787. PubMed ID: 31398253
[TBL] [Abstract][Full Text] [Related]
6. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
[TBL] [Abstract][Full Text] [Related]
7. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
Alvarez RM; Ramanathan P
Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
[TBL] [Abstract][Full Text] [Related]
8. A major increase in oocyte cryopreservation cycles in the USA, Australia and New Zealand since 2010 is highlighted by younger women but a need for standardized data collection.
Johnston M; Richings NM; Leung A; Sakkas D; Catt S
Hum Reprod; 2021 Feb; 36(3):624-635. PubMed ID: 33367704
[TBL] [Abstract][Full Text] [Related]
9. Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.
Crawford S; Boulet SL; Kawwass JF; Jamieson DJ; Kissin DM
Fertil Steril; 2017 Jan; 107(1):110-118. PubMed ID: 27842997
[TBL] [Abstract][Full Text] [Related]
10. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
[TBL] [Abstract][Full Text] [Related]
11. A comparison of live birth rates and perinatal outcomes between cryopreserved oocytes and cryopreserved embryos.
Ho JR; Woo I; Louie K; Salem W; Jabara SI; Bendikson KA; Paulson RJ; Chung K
J Assist Reprod Genet; 2017 Oct; 34(10):1359-1366. PubMed ID: 28718080
[TBL] [Abstract][Full Text] [Related]
12. Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience.
Mayeur A; Puy V; Windal V; Hesters L; Gallot V; Benoit A; Grynberg M; Sonigo C; Frydman N
J Assist Reprod Genet; 2021 Jul; 38(7):1767-1775. PubMed ID: 33797007
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes and utilization from over a decade of planned oocyte cryopreservation.
Leung AQ; Baker K; Vaughan D; Shah JS; Korkidakis A; Ryley DA; Sakkas D; Toth TL
Reprod Biomed Online; 2021 Oct; 43(4):671-679. PubMed ID: 34474973
[TBL] [Abstract][Full Text] [Related]
14. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of oocyte cryopreservation: a meta-analysis.
Oktay K; Cil AP; Bang H
Fertil Steril; 2006 Jul; 86(1):70-80. PubMed ID: 16818031
[TBL] [Abstract][Full Text] [Related]
16. Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases.
Saito S; Yamada M; Yano R; Takahashi K; Ebara A; Sakanaka H; Matsumoto M; Ishimaru T; Utsuno H; Matsuzawa Y; Ooka R; Fukuoka M; Akashi K; Kamijo S; Hamatani T; Tanaka M
J Ovarian Res; 2023 Aug; 16(1):159. PubMed ID: 37563616
[TBL] [Abstract][Full Text] [Related]
17. Oocyte efficiency: does live birth rate differ when analyzing cryopreserved and fresh oocytes on a per-oocyte basis?
Goldman KN; Noyes NL; Knopman JM; McCaffrey C; Grifo JA
Fertil Steril; 2013 Sep; 100(3):712-7. PubMed ID: 23721713
[TBL] [Abstract][Full Text] [Related]
18. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
19. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
20. Reproductive potential of a metaphase II oocyte retrieved after ovarian stimulation: an analysis of 23 354 ICSI cycles.
Stoop D; Ermini B; Polyzos NP; Haentjens P; De Vos M; Verheyen G; Devroey P
Hum Reprod; 2012 Jul; 27(7):2030-5. PubMed ID: 22552690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
